biperiden has been researched along with Panic Disorder in 2 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After biperiden treatment, however, hypercapnia elicited a response profile similar to that elicited by air, whereby subjective anxiety remained similar to preinhalation levels." | 5.09 | Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. ( Battaglia, M; Bellodi, L; Bertella, S; Ogliari, A; Smeraldi, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, H | 1 |
| Kamata, M | 1 |
| Yoshimoto, M | 1 |
| Shimisu, T | 1 |
| Hishikawa, Y | 1 |
| Battaglia, M | 1 |
| Bertella, S | 1 |
| Ogliari, A | 1 |
| Bellodi, L | 1 |
| Smeraldi, E | 1 |
2 trials available for biperiden and Panic Disorder
| Article | Year |
|---|---|
Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Chlorpromazine; Chronic Disease; Depression; Female; Humans; | 1999 |
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder.
Topics: Adult; Age of Onset; Biperiden; Carbon Dioxide; Cross-Over Studies; Female; Humans; Hypercapnia; Hyp | 2001 |